REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2016 13F Holders as of 9/30/2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
177
Total 13F shares, excl. options
31.9M
Shares change
+1.56M
Total reported value, excl. options
$963M
Value change
+$47.8M
Put/Call ratio
2.47
Number of buys
73
Number of sells
-88
Price
$30.19

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2016

207 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2016.
REPLIGEN CORP - COMMON STOCK (RGEN) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31.9M shares of 56.2M outstanding shares and own 56.75% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (2.74M shares), OppenheimerFunds, Inc. (1.94M shares), Invesco Ltd. (1.75M shares), VANGUARD GROUP INC (1.64M shares), FMR LLC (1.57M shares), TimesSquare Capital Management, LLC (1.4M shares), Conestoga Capital Advisors, LLC (1.09M shares), RENAISSANCE TECHNOLOGIES LLC (1.08M shares), DIMENSIONAL FUND ADVISORS LP (1.02M shares), and STATE STREET CORP (943K shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.